{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.09, "exchange": "FRA", "shortName": "RENEURON GRP PLC  LS-,01", "longName": "ReNeuron Group plc", "messageBoardId": "finmb_125064", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683880220, "regularMarketDayHigh": 0.09, "regularMarketDayRange": "0.09 - 0.09", "regularMarketDayLow": 0.09, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.09, "bid": 0.0765, "ask": 0.103, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.09, "averageDailyVolume3Month": 42, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0705, "fiftyTwoWeekLowChangePercent": 3.6153846, "fiftyTwoWeekRange": "0.0195 - 0.406", "fiftyTwoWeekHighChange": -0.31599998, "fiftyTwoWeekHighChangePercent": -0.7783251, "fiftyTwoWeekLow": 0.0195, "fiftyTwoWeekHigh": 0.406, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.15, "sharesOutstanding": 57173800, "bookValue": 0.124, "fiftyDayAverage": 0.07626, "fiftyDayAverageChange": 0.013740003, "fiftyDayAverageChangePercent": 0.18017313, "twoHundredDayAverage": 0.1697925, "twoHundredDayAverageChange": -0.0797925, "twoHundredDayAverageChangePercent": -0.46994123, "marketCap": 5311386, "priceToBook": 0.7258065, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1173855600000, "priceHint": 4, "symbol": "RQE1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Pencoed Business Park", "city": "Pencoed", "zip": "CF35 5HY", "country": "United Kingdom", "phone": "44 20 3819 8400", "website": "https://www.reneuron.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D", "age": 68, "title": "Exec. Chairman", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 173339, "fmt": "173.34k", "longFmt": "173,339"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 37243, "fmt": "37.24k", "longFmt": "37,243"}}, {"maxAge": 1, "name": "Dr. John David Sinden B.A., BA, M.A., MA, Ph.D.", "age": 71, "title": "Co-Founder", "yearBorn": 1951, "fiscalYear": 2002, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John Michael Hawkins A.C.A.", "age": 56, "title": "CFO & Director", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Hancock", "title": "Chief Operations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Randolph  Corteling Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  Dew", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}